IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
